251 results
Page 3 of 13
424B4
vc10v7
17 Feb 21
Prospectus supplement with pricing info
7:14am
8-K
EX-4.1
ga40ke
4 Feb 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.3
6skhysi ugx0
30 Dec 20
Financial Statements and Exhibits
5:13pm
D
b5n296jx3ujl8xqfl
20 Nov 20
$21.15M in equity / options / securities to be acquired, sold $21.15M, 18 investors
3:21pm
8-K
EX-10.8
vndo inbfxfsq7me5
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-3.3
v9i tkco6282m
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-10.4
4itp9
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-14.1
ou48fk
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
d5fs1nl947
9 Oct 20
Other Events
4:03pm
425
knbey 2sarpw6
9 Oct 20
Business combination disclosure
4:01pm
424B3
p1pstdi402q sa
2 Oct 20
Prospectus supplement
9:25am
S-4/A
2oipydmv8c056
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4/A
EX-10.45
hf7fs2pu5h2oo1
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm